Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry

Cavender, Matthew A., Steg, Ph. Gabriel, Smith, Sidney C., Eagle, Kim, Ohman, E. Magnus, Goto, Shinya, Kuder, Julia, Im, Kyungah, Wilson, Peter W.F., Bhatt, Deepak L.·2015·Circulation
DOI 10.1161/circulationaha.114.014796

Cited by (500)

Items 201–300 of 500

  1. Prognostic Value of the Acute-to-Chronic Glycemic Ratio at Admission in Heart Failure: A Prospective Study
    Ma José Carrera, Pedro Moliner, Gemma Llauradó, Cristina Enjuanes, Laura Conangla, Juan José Chillarón, Sílvia Ballesta, Elisenda Climent, Josep Comin Colet, Juana Antonia Flores Le Roux · 2021 · Journal of Clinical Medicine
  2. Management of the ‘wicked’ combination of heart failure and chronic kidney disease in the patient with diabetes
    David S.H. Bell, Janet B. McGill, Terri W. Jerkins · 2023 · Diabetes Obesity and Metabolism
  3. Liver and cardiovascular disease outcomes in metabolic syndrome and diabetic populations: Bi-directional opportunities to multiply preventive strategies
    Alhussain Yasin, Madison Nguyen, Angad Sidhu, Priyanka Majety, Jared Alexander Spitz, Amon Asgharpour, Mohammad Shadab Siddiqui, Laurence S. Sperling, Arshed Ali Quyyumi, Anurag Mehta · 2024 · Diabetes Research and Clinical Practice
  4. Differential pharmacology and clinical utility of dapagliflozin in type 2 diabetes
    Ioanna Papakitsou, George Vougiouklakis, Moses Elisaf, Theodosios D. Filippatos · 2019 · Clinical Pharmacology Advances and Applications
  5. Diabetes and risk of heart failure in people with and without cardiovascular disease: systematic review and meta-analysis
    Kajal Panchal, Claire Alexandra Lawson, Chanchal Chandramouli, Carolyn S.P. Lam, Kamlesh Khunti, Francesco Zaccardi · 2023 · Diabetes Research and Clinical Practice
  6. Age‐dependent prevalence of type 2 diabetes, cardiovascular risk profiles and use of diabetes drugs in Germany using health claims data
    Thorsten Otto, Joanna Diesing, Julia Borchert, Elke Heitmann, Nanette Cathrin Schloot, Jérémie Lebrec, Dirk Müller‐Wieland, Dennis Häckl · 2022 · Diabetes Obesity and Metabolism
  7. Evidence of a bi-directional relationship between heart failure and diabetes: a strategy for the detection of glucose abnormalities and diabetes prevention in patients with heart failure
    Paul Elie Valensi · 2024 · Cardiovascular Diabetology
  8. Association of Diabetic Status and Glycemic Control With Ischemic and Bleeding Outcomes in Patients With Stable Coronary Artery Disease: The 5‐Year CORONOR Registry
    Gilles Lemesle, Thibaud Meurice, Olivier Tricot, Nicolas Lamblin, Christophe Bauters · 2018 · Journal of the American Heart Association
  9. Oral Antiplatelet Therapy for Secondary Prevention of Acute Coronary Syndrome
    Jeffrey S. Berger · 2018 · American Journal of Cardiovascular Drugs
  10. Empagliflozin and Cardio-renal Outcomes in Patients with Type 2 Diabetes and Cardiovascular Disease – Implications for Clinical Practice
    DAVID H. FITCHETT · 2018 · touchREVIEWS in Endocrinology
  11. Cardiovascular outcomes of vildagliptin in patients with type 2 diabetes mellitus after acute coronary syndrome or acute ischemic stroke
    Dong‐Yi Chen, Yanrong Li, Chun‐Tai Mao, Chi‐Nan Tseng, Ching‐Lin Hsieh, Ming‐Jui Hung, Pao‐Hsien Chu, Chao‐Hung Wang, Ming‐Shien Wen, Wen‐Jin Cherng et al. · 2019 · Journal of Diabetes Investigation
  12. G protein‐coupled receptor kinase‐2: A potential biomarker for early diabetic cardiomyopathy
    Shuiqing Lai, Xiaoying Fu, Shufen Yang, Shuting Zhang, Qiu‐Xiong Lin, Mengzhen Zhang, Hongmei Chen · 2019 · Journal of Diabetes
  13. Diagnosis, prevention, and treatment of cardiovascular diseases in people with type 2 diabetes and prediabetes: a consensus statement jointly from the Japanese Circulation Society and the Japan Diabetes Society
    the directors of the JCS, JDS, Eiichi Araki, Atsushi Tanaka, Nobuya Inagaki, Hiroshi Ito, Kohjiro Ueki, Toyoaki Murohara, Kenjiro Imai, Masataka Sata, Takehiro Sugiyama et al. · 2020 · Diabetology International
  14. Combining sodium-glucose cotransporter 2 inhibitors and angiotensin receptor-neprilysin inhibitors in heart failure patients with reduced ejection fraction and diabetes mellitus: A multi-institutional study
    Fu‐Chih Hsiao, Chia‐Pin Lin, Ying‐Chang Tung, Po‐Cheng Chang, John J.V. McMurray, Pao‐Hsien Chu · 2021 · International Journal of Cardiology
  15. Matrix Metalloproteinases and Their Role in Mechanisms Underlying Effects of Quercetin on Heart Function in Aged Zucker Diabetic Fatty Rats
    Barbora Boťanská, Monika Barteková, Kristína Ferenczyová, Mária Fogarassyová, Lucia Kindernay, Miroslav Barančík · 2021 · International Journal of Molecular Sciences
  16. Patient Phenotypes and SGLT-2 Inhibition in Type 2 Diabetes
    Abhinav Sharma, Anne Pernille Ofstad, Tariq Ahmad, Bernard Zinman, Isabella Zwiener, DAVID H. FITCHETT, Christoph Wanner, Jyothis Thomas George, Stefan Hantel, Nihar R. Desai et al. · 2021 · JACC Heart Failure
  17. Nonalcoholic fatty liver disease and diabetes
    Maria Irene Bellini, Irene Urciuoli, Giovanni Del Gaudio, Giorgia Polti, Giovanni Iannetti, Elena Gangitano, Eleonora Lori, Carla Lubrano, Vito Cantisani, Salvatore Sorrenti et al. · 2022 · World Journal of Diabetes
  18. Assessment of medical management in Coronary Type 2 Diabetic patients with previous percutaneous coronary intervention in Spain: A retrospective analysis of electronic health records using Natural Language Processing
    Carlos González‐Juanatey, Manuel P. Anguita-Sánchez, Vivencio Barrios, Ivan Javier Nuñez-Gil, Juan José Gómez-Doblas, Xavier García–Moll, Carlos Lafuente Gormaz, María Jesús Rollán-Gómez, Vicente Peral-Disdie, Luis Martínez‐Dolz et al. · 2022 · PLoS ONE
  19. Effect of Metformin on T2D-Induced MAM Ca2+ Uncoupling and Contractile Dysfunction in an Early Mouse Model of Diabetic HFpEF
    Maya Dia, Christelle Léon, Stéphanie Chanon, Nadia Bendridi, Ludovic Gomez, Jennifer Rieusset, Hélène Thibault, Mélanie Paillard · 2022 · International Journal of Molecular Sciences
  20. The association between serum Sestrin2 and the risk of coronary heart disease in patients with type 2 diabetes mellitus
    Xue Tian, Yu Gao, Min Zhong, Mo-Wei Kong, Li-hua Zhao, Zengbin Feng, Qitian Sun, Jianqiu He, Xiaoyan Liu · 2022 · BMC Cardiovascular Disorders
  21. Diabetes Mellitus and Heart Failure
    Wun-Zhih Siao, Yong-Hsin Chen, Chin‐Feng Tsai, Chun-Ming Lee, Gwo‐Ping Jong · 2022 · Journal of Personalized Medicine
  22. Impact of chronic coronary syndromes on cardiovascular hospitalization and mortality: the ESC-EORP CICD-LT registry
    Mathieu Kernéis, Francesco Cosentino, Roberto Ferrari, Jean‐Louis Georges, Elena Kosmachova, Cécile Laroche, Aldo Pietro Maggioni, Harald Rittger, Philippe Gabríel Steg, Justyna Mączyńska et al. · 2022 · European Journal of Preventive Cardiology
  23. Associated adverse health outcomes of polypharmacy and potentially inappropriate medications in community-dwelling older adults with diabetes
    Lvliang Lu, Shuang Wang, Jiaqi Chen, Yujie Yang, Kai Wang, Jing Zheng, Pi Guo, Yunpeng Cai, Qingying Zhang · 2023 · Frontiers in Pharmacology
  24. Diabetes-related cardiovascular and economic burden in patients hospitalized for heart failure in the US: a recent temporal trend analysis from the National Inpatient Sample
    M. Mekhaimar, S. Dargham, M. El-Shazly, J. Al Suwaidi, H. Jneid, Charbel Abi Khalil · 2020 · Heart Failure Reviews
  25. Cost analysis of chronic heart failure management in Malaysia: A multi-centred retrospective study
    Siew Chin Ong, Joo Zheng Low, WY Yew, Chia How Yen, Muhamad Ali SK Abdul Kader, Houng Bang Liew, Abdul Kahar Abdul Ghapar · 2022 · Frontiers in Cardiovascular Medicine
  26. Dipeptidyl Peptidase-4 Inhibitors and the Risk of Heart Failure
    Faiez M. Zannad, Patrick Rossignol · 2019 · Circulation
  27. Principal predictors of major adverse limb events in diabetic peripheral artery disease: A narrative review
    Federico Biscetti, Andrea Leonardo Cecchini, Maria Margherita Rando, Elisabetta Nardella, Antonio Gasbarrini, Massimo Massetti, Andrea Flex · 2021 · Atherosclerosis Plus
  28. Multifocal atherosclerosis: focus on the prevention of ischemic events
    A. G. Arutyunov, Т. И. Батлук, R. A. Bashkinov, M. A. Trubnikova · 2021 · Russian Journal of Cardiology
  29. Comparing benefits from sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in randomized clinical trials: a network meta-analysis
    SABOURET, Pierre, BOCCHINO, Pier P., ANGELINI, Filippo, D’ASCENZO, Fabrizio, GALATI, Giuseppe, FYSEKIDIS, Marinos, DE FERRARI, Gaetano M., FISCHMAN, David L., BHATT, Deepak L., BIONDI-ZOCCAI, Giuseppe · 2023 · Minerva Cardiology and Angiology
  30. Molecular circadian clock disruption in the leukocytes of individuals with type 2 diabetes and overweight, and its relationship with leukocyte–endothelial interactions
    Clara Luna-Marco, Deédeni Devos, Julia Cacace, Meylin Fernández-Reyes, Pedro Díaz-Pozo, Juan Diego Salazar, Eva Solá, Carlos Morillas, Milagros Rocha, Víctor M. Víctor et al. · 2024 · Diabetologia
  31. Cardiovascular risk reduction in type 2 diabetes: What the non‐specialist needs to know about current guidelines
    Matthew R. Weir · 2024 · Diabetes Obesity and Metabolism
  32. Clopidogrel Resistance in a Murine Model of Diet-Induced Obesity Is Mediated by the Interleukin-1 Receptor and Overcome With DT-678
    Yifang Sun, Jessica Venugopal, Chiao Guo, Yanbo Fan, Jianping Li, Yanjun Gong, Y. Eugene Chen, Haoming Zhang, Daniel T. Eitzman · 2020 · Arteriosclerosis Thrombosis and Vascular Biology
  33. Galectin-3 for prediction of cardiac function compared to NT-proBNP in individuals with prediabetes and type 2 diabetes mellitus
    Volker H. Schmitt, Jürgen H. Prochaska, A. Föll, Andreas Schulz, Karsten Keller, Omar Hahad, Thomas Koeck, Sven‐Oliver Tröbs, Steffen Rapp, Manfred Elmar Beutel et al. · 2021 · Scientific Reports
  34. Use of optimal medical therapy in patients with diabetes and atherosclerotic cardiovascular disease: Insights from a prospective longitudinal cohort study
    Suzanne V. Arnold, James A. de Lemos, Luke Zheng, Robert S. Rosenson, Christie Mitchell Ballantyne, Shushama Alam, Deepak L. Bhatt, Christopher Paul Cannon, Mikhail Kosiborod, the GOULD Investigators · 2023 · Diabetes Obesity and Metabolism
  35. Fitterfly Diabetes CGM Digital Therapeutics Program for Glycemic Control and Weight Management in People With Type 2 Diabetes Mellitus: Real-world Effectiveness Evaluation
    Shilpa Joshi, Ritika Verma, Tejal Bipin Lathia, Chitra Selvan, Snehal Tanna, Amit Saraf, MANGESH HARIHAR TIWASKAR, Alok Modi, Sanjay Kalra, K Vasudevarao et al. · 2023 · JMIR Diabetes
  36. The chronic ischaemic cardiovascular disease ESC Pilot Registry: Results of the six-month follow-up
    Michel Komajda N, Mathieu Kernéis, Luigi Tavazzi, Serban Mihai Balanescu, Francesco Cosentino, Alberto Cremonesi, Roberto Ferrari, Serge Kownator, Hanna Szwed, Iveta Mintāle et al. · 2018 · European Journal of Preventive Cardiology
  37. Análisis de las hospitalizaciones por enfermedad cardiovascular en población diabética en España
    Antonio Zapatero, Ricardo Gómez‐Huelgas, Jesús Canora, Javier Ena Muñoz, Marta Romero-Sánchez, Manuel Méndez‐Bailón, Javier Marco-Martínez, Raquel Barba · 2018 · Revista Clínica Española
  38. Impact of hypoglycemia at the time of hospitalization for heart failure from emergency department on major adverse cardiovascular events in patients with and without type 2 diabetes
    Seon‐Ah Cha, Jae‐Seung Yun, Gee-Hee Kim, Yu‐Bae Ahn · 2022 · Cardiovascular Diabetology
  39. Longer leukocyte telomere length increases cardiovascular mortality in type 2 diabetes patients
    Ziwei Chen, Yao Shen, Jing He, Yang Shen, Weida Zhu, Xiaohui Wu, Mingbing Xiao · 2023 · Journal of Diabetes
  40. Risk factors for heart failure hospitalizations among patients with atrial fibrillation
    Lucien Eggimann, Steffen Blum, Stefanie Aeschbacher, Andreas Reusser, Peter Ammann, Paul Erné, Giorgio Moschovitis, Marcello Di Valentino, Dipen C. Shah, Jürg Schläpfer et al. · 2018 · PLoS ONE
  41. Safety and efficacy of linagliptin in patients with type 2 diabetes mellitus and coronary artery disease: Analysis of pooled events from 19 clinical trials
    Michael Lehrke, Lawrence A. Leiter, Uwe Hehnke, Sandra Thiemann, Amit Bhandari, Thomas W. Meinicke, Odd Erik Johansen · 2016 · Journal of Diabetes and its Complications
  42. Diabetes Mellitus Is Not a Risk Factor for Patients Supported With Left Ventricular Assist Device
    Pengyu Zhou, Zezhou Xiao, Peng Zhu, Zhiqiang Nie, Desai Pavan, Shaoyi Zheng · 2019 · The Annals of Thoracic Surgery
  43. Comparison of clinical outcomes and left ventricular remodeling after ST-elevation myocardial infarction between patients with and without diabetes mellitus
    Naoyuki Akashi, Takunori Tsukui, Kei Yamamoto, Masaru Seguchi, Yousuke Taniguchi, Kenichi Sakakura, Hiroshi Wada, Shin‐ichi Momomura, Hideo Fujita · 2021 · Heart and Vessels
  44. Prevalence, prescriptions, outcomes and costs of type 2 diabetes patients with or without prior coronary artery disease or stroke: a longitudinal 5-year claims-data analysis of over 7 million inhabitants
    Aldo Pietro Maggioni, Letizia Dondi, Felicita Andreotti, Giulia Ronconi, Silvia Calabria, Carlo Pasquale Piccinni, Antonella Pedrini, Imma Esposito, Nello Martini · 2021 · Therapeutic Advances in Chronic Disease
  45. Association of mental health with the risk of coronary artery disease in patients with diabetes: A mendelian randomization study
    Teng Hu, Fangkun Yang, Kewan He, Jiajun Ying, Hanbin Cui · 2022 · Nutrition Metabolism and Cardiovascular Diseases
  46. Is non-alcoholic fatty liver disease a sign of left ventricular diastolic dysfunction in patients with type 2 diabetes mellitus? A systematic review and meta-analysis
    Sicheng Wang, Xiangyuan Zhang, Qiqi Zhang, Boxun Zhang, Linhua Zhao · 2023 · BMJ Open Diabetes Research & Care
  47. Accurate diagnosis of severe coronary stenosis based on resting magnetocardiography: a prospective, single-center, cross-sectional analysis
    Jian-Guo CUI, Feng TIAN, Yu-Hao MIAO, Qin-Hua JIN, Yajun Shi, Li Li, Meng-Jun SHEN, Xiaoming Xie, Shu-Lin ZHANG, Yundai Chen · 2024 · 老年心脏病学杂志：英文版
  48. Development and validation of a model to predict cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke in patients with type 2 diabetes mellitus and established atherosclerotic cardiovascular disease
    Susanna R. Stevens, Matthew W. Segar, Ambarish Pandey, Yuliya V. Lokhnygina, Jennifer B. Green, Darren K. McGuire, Eberhard Standl, Eric David Peterson, Rury R. Holman · 2022 · Cardiovascular Diabetology
  49. Derivation and External Validation of a Clinical Model to Predict Heart Failure Onset in Patients With Incident Diabetes
    Louise Y. Sun, Salwa S. Zghebi, Anan Bader Eddeen, Peter P. Liu, Douglas S. Lee, Karen Tu, Sheldon W. Tobe, Evangelos Kontopantelis, Mamas A. Mamas · 2022 · Diabetes Care
  50. Dual antiplatelet therapy in patients with diabetes and acute coronary syndromes managed without revascularization
    Anthony J. Dalby, Shmuel Gottlieb, Derek D. Cyr, E. Magnus Ohman, Darren K. McGuire, Witold Rużyłło, Deepak L. Bhatt, Stephen D. Wiviott, Kenneth J. Winters, Keith A.A. Fox et al. · 2017 · American Heart Journal
  51. Prognostic Impact of Fasting Plasma Glucose on Mortality and Re-Hospitalization in Patients with Acute Heart Failure
    Yu-Yang Chen, Yuan Chen, Shu-Min Liang, Zi-Zhuo Su, Xiaorong Shu, Hai-Feng Zhang, Siu‐Hin Wan, Jing-Feng Wang, Shuang-Lun Xie · 2018 · Chinese Medical Journal
  52. Management of patients with diabetes and heart failure with reduced ejection fraction: An international comparison
    Suzanne V. Arnold, Jonathan Jiunn Liang Yap, Carolyn S.P. Lam, Fengming Tang, Wan Ting Tay, Tiew‐Hwa Katherine Teng, Darren K. McGuire, James L. Januzzi, Gregg C. Fonarow, Frederick A. Masoudi et al. · 2018 · Diabetes Obesity and Metabolism
  53. Acupuncture and related techniques for type 2 diabetes mellitus
    Meilu Liu, Jianrong Chen, Qing Ren, Weifeng Zhu, Dongmei Yan, Heyun Nie, Xiaofan Chen, Xu Zhou · 2019 · Medicine
  54. Diabetes Increases Risk of Cardiovascular Events in Patients Receiving Permanent Pacemaker: A Propensity Score-Matched Cohort Study
    Huang‐Chung Chen, Wenhao Liu, Chien-Hao Tseng, Yung‐Lung Chen, Wei‐Chieh Lee, Yen‐Nan Fang, Shaur-Zheng Chong, Mien‐Cheng Chen · 2022 · Journal of Diabetes Research
  55. Radiomics of pericoronary adipose tissue on computed tomography angiography predicts coronary heart disease in patients with type 2 diabetes mellitus
    Shumei Miao, Feihong Yu, Rongrong Sheng, Xiaoliang Zhang, Yong Li, Yaolei Qi, Shan Lu, Pei Ji, Jiyue Fan, Xin Zhang et al. · 2024 · BMC Cardiovascular Disorders
  56. Modeling heart failure risk in diabetes and kidney disease: limitations and potential applications of transverse aortic constriction in high-fat-fed mice
    Wei Tan, THOMAS P. MULLINS, Melanie Flint, Sarah L. Walton, Helle Bielefeldt‐Ohmann, David A. Carter, Meera R. Gandhi, Hayley R. McDonald, Joan Li, Karen M. Moritz et al. · 2018 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
  57. Analysis of hospitalizations by cardiovascular disease in the population with diabetes in Spain
    Antonio Zapatero, Ricardo Gómez‐Huelgas, Jesús Canora, Javier Ena Muñoz, Marta Romero-Sánchez, Manuel Méndez‐Bailón, Javier Marco-Martínez, Raquel Barba · 2018 · Revista Clínica Española (English Edition)
  58. Pericardial fat versus BMI in the assessment of coronary atherosclerotic burden in patients with diabetes mellitus
    Hussein Nafakhi, Abdulameer A. Al‐Mosawi, Mundher M. Mudhafar · 2019 · Acta Diabetologica
  59. Registry Assessment of Peripheral Interventional Devices objective performance goals for superficial femoral and popliteal artery peripheral vascular interventions
    Daniel J. Bertges, Roseann White, Yu‐Ching Cheng, Tian-Yi Sun, Niveditta Ramkumar, Philip P. Goodney, Rebecca W. Wilgus, Aaron E. Lottes, Joshua A. Smale, Joseph P. Drozda et al. · 2020 · Journal of Vascular Surgery
  60. Type 2 Diabetes Risk in Older Adults Living in Social Housing: A Cross-Sectional Study
    Ricardo N. Angeles, Ying Guo Zhu, Melissa Pirrie, Francine Marzanek, Gina Agarwal · 2020 · Canadian Journal of Diabetes
  61. Incidence and risks of coronary heart disease and heart failure in Japanese patients with type 2 diabetes mellitus: The Fukuoka diabetes registry
    Masanori Iwase, Toshiaki Ohkuma, Hiroki Fujii, Yutaro Oku, Taiki Higashi, Ayaka Oshiro, Hitoshi Ide, Udai Nakamura, Takanari Kitazono · 2023 · Diabetes Research and Clinical Practice
  62. Routine stress testing in diabetic patients after percutaneous coronary intervention: the POST-PCI trial
    Hoyun Kim, Do‐Yoon Kang, Jinho Lee, Yeonwoo Choi, Jung‐Min Ahn, Seon‐Ok Kim, Yong‐Hoon Yoon, Seung‐Ho Hur, Cheol Hyun Lee, Won‐Jang Kim et al. · 2023 · European Heart Journal
  63. Long-term training in diabetes-related knowledge, attitudes, and self-reported practice among diabetes liaison nurses
    Wen Zhou, Jin Huang, Lingfeng Yang, Tieying Qiu, Yan Zhang, Fang Liu, Zhiguang Zhou · 2019 · Journal of International Medical Research
  64. The cholesterol paradox may be attenuated in heart failure patients with diabetes
    Filipe Manuel Cunha, Joana Certo Pereira, Ana Ribeiro, Sérgio Silva, José Paulo Araújo, Adelino Ferreira Leite-Moreira, Paulo Bettencourt, Patrícia Lourenço · 2020 · Minerva Medica
  65. Absence of Endothelial ERα Results in Arterial Remodeling and Decreased Stiffness in Western Diet–Fed Male Mice
    Camila Manrique‐Acevedo, Francisco I. Ramirez‐Perez, Jaume Padilla, Victoria J. Vieira‐Potter, Annayya Rao Aroor, Brady J. Barron, Dongqing Chen, Dominic Haertling, Cory E. DeClue, James R. Sowers et al. · 2017 · Endocrinology
  66. Telemedicine home-based management in patients with chronic heart failure and diabetes type II: study protocol for a randomized controlled trial
    Palmira Bernocchi, Vittorio Giudici, Gabriella Borghi, Patrizia Bertolaia, Salvatore D’Isa, Roberto Trevisan, Simonetta Scalvini · 2024 · Trials
  67. Prognostic implications of fasting plasma glucose in subjects with echocardiographic abnormalities
    Manan Pareek, Muthiah Vaduganathan, Deepak L. Bhatt, Margrét Leósdóttir, Michael Hecht Olsen · 2017 · International Journal of Cardiology
  68. Mineralocorticoids and Cardiovascular Disease in Females with Insulin Resistance and Obesity
    Manav Nayyar, Guido Lastra, Camila Manrique‐Acevedo · 2018 · Current Hypertension Reports
  69. Extended dual antiplatelet therapy for Asian patients with acute coronary syndrome: expert recommendations
    Walter W. C. Chen, Kwan‐Kin Law, Shu-Kin Li, William C.K. Chan, Adrian Cheong, Ping‐Ching Fong, Yu‐Tak Hung, Steve W.K. Lai, Godwin Tat-Chi Leung, Edmond Wong et al. · 2019 · Internal Medicine Journal
  70. Targeting the DPP-4-GLP-1 pathway improves exercise tolerance in heart failure patients: a systematic review and meta-analysis
    Chengcong Chen, Ying Huang, Yongmei Zeng, Xiyan Lu, Guoqing Dong · 2019 · BMC Cardiovascular Disorders
  71. Clinical characteristics and quality assessment of the treatment of patients with chronic heart failure with diabetes mellitus
    N. V. Lazareva, Е. В. Ощепкова, А. A. Orlovsky, S. N. Тereschenko · 2020 · Terapevticheskii arkhiv
  72. Prognostic Significance of Preprocedural N-Terminal Pro-B-Type Natriuretic Peptide Assessment in Diabetic Patients With Multivessel Coronary Disease Undergoing Revascularization
    Le Wang, Hongliang Cong, Jingxia Zhang, Yuecheng Hu, Ximing Li, Ying-yi Zhang, Lin Wang, Hua Yang, Libin Ren, Wei Qi et al. · 2021 · Frontiers in Cardiovascular Medicine
  73. Potential diabetic cardiomyopathy therapies targeting pyroptosis: A mini review
    Jia Yu, Dongze Li, Jing Yuan Yu, Wenli Jiang, Xiaoyang Liao, Qian Zhao · 2022 · Frontiers in Cardiovascular Medicine
  74. Relationship Between Epicardial Adipose Tissue and Biventricular Longitudinal Strain and Strain Rate in Patients with Type 2 Diabetes Mellitus
    Jing Zhu, Wenjia Li, Zhen Xie, Kaimin Zhuo · 2022 · Academic Radiology
  75. The Impact of Drying and Salting on the Fish Resilience and Quality
    Rani Rani, Nurhidayati Sholihah, Fadzilatul Mutmainah, Sopiah Sopiah, Rahmi Rahmi, Nur Aisyah, Eni Marta · 2022 · International Journal of Natural Science and Engineering
  76. Assessing risk of future cardiovascular events, healthcare resource utilization and costs in patients with type 2 diabetes, prior cardiovascular disease and both
    Chi Nguyen, Rakesh Luthra, Effie L. Kuti, Vincent J. Willey · 2020 · Current Medical Research and Opinion
  77. Patients With Type 2 Diabetes Mellitus and Heart Failure Benefit More From Sodium-Glucose Cotransporter 2 Inhibitor: A Systematic Review and Meta-Analysis
    Chengcong Chen, Hong Peng, Mingzhu Li, Xiyan Lu, Miao Huang, Yongmei Zeng, Guoqing Dong · 2021 · Frontiers in Endocrinology
  78. Time to Death and Its Determinant Factors Among Patients With Chronic Heart Failure in Northwest Ethiopia: A Retrospective Study at Selected Referral Hospitals
    Yikeber Abebaw Moyehodie, Mitiku Wale Muluneh, Alebachew Taye Belay, Setegn Muche Fenta · 2022 · Frontiers in Cardiovascular Medicine
  79. Impact of dronedarone on patients with atrial fibrillation and diabetes: A sub-analysis of the ATHENA and EURIDIS/ADONIS studies
    Yehuda Handelsman, Thomas Jared Bunch, Helena W. Rodbard, Benjamin Adam Steinberg, Munveer Thind, Grégory Bigot, L Konigsberg, Mattias Wieloch, Peter Russell Kowey · 2022 · Journal of Diabetes and its Complications
  80. Atherosclerotic Cardiovascular Disease in Diabetes Patients
    Rina Amelia, Arlinda Sari Wahyuni, Yuki Yunanda, Hendri Wijaya · 2023 · Current Diabetes Reviews
  81. WATCH-DM risk score predicts the prognosis of diabetic phenotype patients with heart failure and preserved ejection fraction
    Xinxin Zhang, Xin Lv, Ning Wang, Songqi Yu, Jinping Si, Yanli Zhang, Mingxu Cai, Ying Liu · 2023 · International Journal of Cardiology
  82. Interdependence between myocardial deformation and perfusion in patients with T2DM and HFpEF: a feature-tracking and stress perfusion CMR study
    Xinni Li, Yuting Liu, Sang Kang, Dan Yang, Huo-Yuan Xiao, Wenkun Ma, Chengxing Shen, Jing-Wei Pan · 2024 · Cardiovascular Diabetology
  83. Second revolution in cardiovascular prevention
    Chern‐En Chiang, Kang-Ling Wang, Hao‐Min Cheng, Shih‐Hsien Sung, Tze‐Fan Chao · 2020 · Journal of the Chinese Medical Association
  84. Towards quadruple therapy for heart failure with reduced ejection fraction: DAPA-HF secondary analysis data
    Zh. D. Kobalava, Vadim Medovchshikov, Nurlan Yeshniyazov · 2020 · Russian Journal of Cardiology
  85. Contribution of ESC DAPT guideline-endorsed high thrombotic risk features to long-term clinical outcomes among patients with and without high bleeding risk after PCI
    Haoyu Wang, Kefei Dou, Dong Yin, Dong Zhang, Run-Lin Gao, Yuejin Yang · 2020 · BMC Cardiovascular Disorders
  86. Adherence to the National Guidelines for Follow-Up Protocol in Subjects with Type 2 Diabetes Mellitus in Greece: The GLANCE Study
    N. Papanas, M. Elisaf, K. Kotsa, A. Melidonis, S. Bousboulas, A. Bargiota, E. Pagkalos, J. Doupis, I. Ioannidis, I. Avramidis et al. · 2020 · Diabetes Therapy
  87. Inverse Associations Between Circulating Secreted Frizzled Related Protein 2 (sFRP2) and Cardiometabolic Risk Factors
    Mengying Cao, Hao Wang, Wenshu Li, Xueli Jiang, Xiaolin Wang, Wei Guo, Pan Gao, Yunzeng Zou · 2021 · Frontiers in Cardiovascular Medicine
  88. Influence of diabetes mellitus interactions with cardiovascular risk factors on post-myocardial infarction heart failure hospitalizations
    Srikanth Yandrapalli, Aaqib Habib Malik, Fnu Namrata, Gayatri Pemmasani, Dhrubajyoti Bandyopadhyay, Saraschandra Vallabhajosyula, Wilbert S. Aronow, William H. Frishman, Diwakar Jain, Howard A. Cooper et al. · 2021 · International Journal of Cardiology
  89. Change of Exhaled Acetone Concentration in a Diabetic Patient with Acute Decompensated Heart Failure
    Tetsuro Yokokawa, Yasuhiro Ichijo, Yu Houtsuki, Yoshiyuki Matsumoto, Masayoshi Oikawa, Akiomi Yoshihisa, Koichi Sugimoto, Kazuhiko Nakazato, Hitoshi Suzuki, Shu‐ichi Saitoh et al. · 2017 · International Heart Journal
  90. Assessment of the high risk and unmet need in patients with CAD and type 2 diabetes (ATHENA): US healthcare resource utilization, cost and burden of illness in the Diabetes Collaborative Registry
    Eric T Wittbrodt, Narinder P. Bhalla, Karolina Andersson Sundell, Qi Gao, Liyan Dong, Matthew Aaron Cavender, Phillip R. Hunt, Nathan D. Wong, Carl Mellström · 2020 · Endocrinology Diabetes & Metabolism
  91. Paving the Road Toward Exploiting the Therapeutic Effects of Ginsenosides: An Emphasis on Autophagy and Endoplasmic Reticulum Stress
    Milad Ashrafizadeh, Shima Tavakol, Reza Mohammadinejad, Zahra Ahmadi, Habib Yaribeygi, Tannaz Jamialahmadi, Thomas Patrick Johnston, Amirhossein Sahebkar · 2021 · Advances in experimental medicine and biology
  92. Glycated Hemoglobin and Outcomes of Heart Failure (from Get With the Guidelines-Heart Failure)
    Justin Basile Echouffo-Tcheugui, Shubin Sheng, Adam D. DeVore, Roland Matsouaka, Adrian F. Hernandez, Clyde W. Yancy, Paul A. Heidenreich, Deepak L. Bhatt, Gregg C. Fonarow · 2018 · The American Journal of Cardiology
  93. The continuous challenge of antithrombotic strategies in diabetes: focus on direct oral anticoagulants
    Fulvio Pomero, Francesco Dentali, Nicola Mumoli, Pietro Salomone, Flavio Tangianu, Giovambattista Desideri, Daniela Mastroiacovo · 2019 · Acta Diabetologica
  94. Quantifying the Risk Continuum for Cardiovascular Death in Adults with Type 2 Diabetes
    Brent A. Williams, James C. Blankenship, Stephen J. Voyce, Jeanine M. Cordova, Pranav Gandhi, Sharash S. Shetty · 2021 · Canadian Journal of Diabetes
  95. Modifiers of the Risk of Diabetes for Long-Term Outcomes After Coronary Revascularization
    Kyohei Yamaji, Hiroki Shiomi, Takeshi Morimoto, Yukiko Matsumura‐Nakano, Natsuhiko Ehara, Hiroki Sakamoto, Yasuaki Takeji, Yusuke Yoshikawa, Ko Yamamoto, Eri Toda Kato et al. · 2022 · JACC Asia
  96. Circulating Prolidase Activity in Patients with Myocardial Infarction
    Adnan Sultan, Yuting Zheng, Patrick James Trainor, Yong Siow, Alok Ravindra Amraotkar, Bradford G. Hill, Andrew Paul DeFilippis · 2017 · Frontiers in Cardiovascular Medicine
  97. Compared impact of diabetes on the risk of heart failure from acute myocardial infarction to chronic coronary artery disease
    Gilles Lemesle, Étienne Puymirat, Laurent Bonello, Tabassome Simon, Philippe Gabríel Steg, Jean Ferrières, François Schiele, Laurent Fauchier, Patrick Henry, Guillaume Schurtz et al. · 2021 · Diabetes & Metabolism
  98. Cost–effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease: a European economic evaluation of the THEMIS trial
    Philippe Gabríel Steg, Deepak L. Bhatt, Stefan Karl James, Oliver T. Darlington, Louise Hoskin, Tabassome Simon, Kim Michael Fox, Lawrence A. Leiter, Shamir R. Mehta, Robert A. Harrington et al. · 2022 · European Heart Journal - Cardiovascular Pharmacotherapy
  99. Quantitative MRI in cardiometabolic disease: From conventional cardiac and liver tissue mapping techniques to multi-parametric approaches
    Anastasia Fotaki, Carlos Velasco, Claudia Prieto, René Michael Botnar · 2023 · Frontiers in Cardiovascular Medicine
  100. Antiplatelet Therapy in Diabetes
    Arjun Majithia, Deepak L. Bhatt · 2017 · Endocrinology and Metabolism Clinics of North America